Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Genetic inhibition of CARD9 accelerates the development of experimental atherosclerosis through CD36 dependent-defective autophagy

View through CrossRef
Abstract Macrophage-mediated innate immune responses contribute to the initiation, progression and complications of atherosclerosis. However, the underlying pathways linking activation of macrophages to atherosclerotic plaque develoment are still poorly understood. We hypothesized that activation of caspase recruitment-domain containing protein 9 (CARD9) plays a determinant role in pro-atherogenic responses in macrophages. We showed that global deletion of Card9 in male Apoe −/− mice as well as hematopoietic deletion of Card9 in female Ldlr −/− mice increased atherosclerosis. Card9 −/− chimeric animals displayed more inflammatory atherosclerotic plaques and decreased systemic Th17 responses when compared to Card9 +/+ chimeric mice. The acceleration of atherosclerosis was also observed in Apoe −/− Rag2 −/− Card9 −/− mice lacking T, B, and NKT cells, ruling out a role for the adaptive immune system in the pro-atherogenic effect of Card9 deficiency. Card9 deficiency altered macrophage phenotype with increased production of pro-inflammatory cytokines, improved lipid uptake, higher cell death susceptibility and defective autophagy. Rapamycin or metformin, two autophagy inducers, abolished intracellular lipid overload, restored macrophage survival and autophagy flux i n vitro and finally abolished the pro-atherogenic effects of Card9 deficiency in vivo. Card9 deficiency up-regulated Cd36 expression in macrophages, which blocked AMPK phosphorylation, a key inducer of autophagy. In the absence of Cd36 , the pro-atherogenic effects of Card9 deficiency were blunted both in vitro and in vivo . Transcriptomic analysis of human monocytes isolated from CARD9 -deficient patients confirmed the pathogenic signature identified in murine models. In summary, we identified CARD9 signaling as a key protective pathway in atherosclerosis, modulating macrophage CD36-dependent inflammatory responses, lipid uptake and autophagy.
Title: Genetic inhibition of CARD9 accelerates the development of experimental atherosclerosis through CD36 dependent-defective autophagy
Description:
Abstract Macrophage-mediated innate immune responses contribute to the initiation, progression and complications of atherosclerosis.
However, the underlying pathways linking activation of macrophages to atherosclerotic plaque develoment are still poorly understood.
We hypothesized that activation of caspase recruitment-domain containing protein 9 (CARD9) plays a determinant role in pro-atherogenic responses in macrophages.
We showed that global deletion of Card9 in male Apoe −/− mice as well as hematopoietic deletion of Card9 in female Ldlr −/− mice increased atherosclerosis.
Card9 −/− chimeric animals displayed more inflammatory atherosclerotic plaques and decreased systemic Th17 responses when compared to Card9 +/+ chimeric mice.
The acceleration of atherosclerosis was also observed in Apoe −/− Rag2 −/− Card9 −/− mice lacking T, B, and NKT cells, ruling out a role for the adaptive immune system in the pro-atherogenic effect of Card9 deficiency.
Card9 deficiency altered macrophage phenotype with increased production of pro-inflammatory cytokines, improved lipid uptake, higher cell death susceptibility and defective autophagy.
Rapamycin or metformin, two autophagy inducers, abolished intracellular lipid overload, restored macrophage survival and autophagy flux i n vitro and finally abolished the pro-atherogenic effects of Card9 deficiency in vivo.
Card9 deficiency up-regulated Cd36 expression in macrophages, which blocked AMPK phosphorylation, a key inducer of autophagy.
In the absence of Cd36 , the pro-atherogenic effects of Card9 deficiency were blunted both in vitro and in vivo .
Transcriptomic analysis of human monocytes isolated from CARD9 -deficient patients confirmed the pathogenic signature identified in murine models.
In summary, we identified CARD9 signaling as a key protective pathway in atherosclerosis, modulating macrophage CD36-dependent inflammatory responses, lipid uptake and autophagy.

Related Results

Abstract 585: Card9 Deficiency Accelerates Experimental Atherosclerosis
Abstract 585: Card9 Deficiency Accelerates Experimental Atherosclerosis
Introduction: There are accumulating evidences that innate and adaptive immunity play a major role in the development of atherosclerosis. Pattern-recognition receptors ...
TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages
TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages
ABSTRACT Atherosclerosis is the major cause of ischemic heart diseases and ischemic brain stroke, which are the leading causes of mortality world...
Foamy Monocytes Form Early and Contribute to Nascent Atherosclerosis in Mice With Hypercholesterolemia
Foamy Monocytes Form Early and Contribute to Nascent Atherosclerosis in Mice With Hypercholesterolemia
Objective— To examine infiltration of blood foamy monocytes, containing intracellular lipid droplets, into early atherosclerotic lesions and its contribution to develop...
Dysregulated lipolysis and lipophagy in lipid droplets of macrophages from high fat diet‐fed obese mice
Dysregulated lipolysis and lipophagy in lipid droplets of macrophages from high fat diet‐fed obese mice
AbstractObesity is associated with lipid droplet (LD) accumulation, dysregulated lipolysis and chronic inflammation. Previously, the caspase recruitment domain‐containing protein 9...
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract Considering that a tumor promoting role for GSK3 has been suggested in pancreatic cancer (PC) cells and that GSK3 inhibitors are currently under clinical tr...
Abstract 409: Ambient Fine Particulate Matter Impairs Endothelial Progenitor Cells Through Card9-mediated Innate Immune Response
Abstract 409: Ambient Fine Particulate Matter Impairs Endothelial Progenitor Cells Through Card9-mediated Innate Immune Response
Background/Aims: Endothelial progenitor cells (EPCs) play a critical role in angiogenesis and vascular repair. Some environmental insults, like fine particulate matter ...

Back to Top